Samantha Pennington, PHARMD - Pharmacist in Malvern, AR

Samantha Pennington, PHARMD is a Pharmacist based in Malvern, Arkansas. Samantha Pennington is licensed to practice in Arkansas (license number PD15342) and her current practice location is 1402 Mlk Blvd, Malvern, Arkansas. She can be reached at her office (for appointments etc.) via phone at (501) 229-1446.

NPI number for Samantha Pennington is 1154933950 and her current mailing address is 126 Big Creek Rd, Malvern, Arkansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1154933950.

Contact Information

Samantha Pennington, PHARMD
1402 Mlk Blvd,
Malvern, AR 72104-2105
(501) 229-1446
Not Available

Healthcare Provider's Profile

Full NameSamantha Pennington
GenderFemale
SpecialityPharmacist
Location1402 Mlk Blvd, Malvern, Arkansas
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1154933950
  • Provider Enumeration Date: 08/21/2020
  • Last Update Date: 08/21/2020

Medical Identifiers

Medical identifiers for Samantha Pennington such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1154933950NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist PD15342 (Arkansas)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Samantha Pennington is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Samantha Pennington, PHARMD
126 Big Creek Rd,
Malvern, AR 72104-6427

Ph: (501) 337-6396
Samantha Pennington, PHARMD
1402 Mlk Blvd,
Malvern, AR 72104-2105

Ph: (501) 229-1446

News Archive

FDA grants Exelixis XL184 orphan drug designation for treatment of medullary thyroid cancer

Exelixis, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted orphan drug designation to XL184 for treatment of follicular, medullary, and anaplastic thyroid carcinoma, and metastatic or locally advanced papillary thyroid cancer. A pivotal phase 3 trial of XL184 is ongoing in patients with medullary thyroid cancer (MTC) and the company expects to release top-line phase 3 results in the first-half of 2011 and potentially file a New Drug Application (NDA) for the compound in the second-half of 2011.

Mapping premature infant's brain after birth may help better predict developmental problems

Scanning a premature infant's brain shortly after birth to map the location and volume of lesions, small areas of injury in the brain's white matter, may help doctors better predict whether the baby will have disabilities later, according to a new study published in the January 18, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Discovery provides new insights into how asthma may be caused

Researchers from the University of Leicester and University Hospitals of Leicester NHS Trust, working with the National Institute of Allergy and Infectious Diseases and Genentech, have discovered new insights into how asthma may be caused, by identifying three distinct groups of asthma patients characterised by the activity of different genes in an individual's airways.

Study expands knowledge about sexuality and gender gaps in political attitudes

A University of Oklahoma sociologist, Meredith Worthen, has published a new study in the journal, Sexuality Research and Social Policy, on sexuality and gender gaps in political perspectives among lesbian, gay, bisexual, mostly heterosexual and heterosexual college students in the southern United States.

Read more News

› Verified 6 days ago


Pharmacist in Malvern, AR

Shalonda Macon,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 308 S Main St, Malvern, AR 72104
Phone: 501-467-8197    
Dr. Amber Elizabeth Prescott, PHARM.D.
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 308 S Main St, Malvern, AR 72104
Phone: 501-467-8192    Fax: 501-467-8662
Deborah Cooper Brumley, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1001 Schneider Dr, Malvern, AR 72104
Phone: 501-332-7356    
Justin Clark Jones,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 224 Harmony Acres Rd, Malvern, AR 72104
Phone: 501-337-6015    
Jamelyn Landes, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 308 S Main St, Malvern, AR 72104
Phone: 501-467-8197    
Dr. Joshua Daniel Robinson, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 509 Reyburn Creek Rd, Malvern, AR 72104
Phone: 479-595-4977    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.